fibrosis

Type: Keyphrase
Name: fibrosis
First reported 20 mins ago - Updated 20 mins ago - 1 reports

Vitamin D prevents intestinal fibrosis in IBD

(foodconsumer.org) -- Patients with inflammatory bowel disease (IBD) may be better off taking vitamin D supplements as a new study conducted in China found a diet full of the sunshine vitamin may have a prophylactic effect on intestinal fibrosis in mice ... [Published Food Consumer - 20 mins ago]
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Printable Body Parts Leap Forward with Printed Jaw

A partial list of objects made with 3D printing technology in the past year:A working acoustic guitar Miniature replicas of human beings made from photos All components for a 2,400 square foot house (in under 24 hours) A functioning pistol (but not ... [Published PSFK - 4 hours ago]
First reported 11 hours ago - Updated 4 hours ago - 1 reports

ProMetic Seeks Orphan Status For Lead IPF Drug

By Estel Grace MasangkayBiopharmaceutical company ProMetic Life Sciences announced its intent to pursue idiopathic pulmonary fibrosis (IPF) as an orphan indication for its lead drug candidate PBI-4050.PBI-4050 is an orally active drug being developed ... [Published Bioresearch Online - 11 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Roche's Esbriet Gets US FDA Nod for IPF Treatment

Roche announced that the US Food and Drug Administration (FDA) has approved Esbriet (pirfenidone) as a treatment for idiopathic pulmonary fibrosis (IPF) in the United States. IPF is a fatal disease caused by progressive scarring (fibrosis) of the lungs, ... [Published PharmaAsia - 7 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Muscle Fibrosis Spurred by Out-Of-Step Cells Duchenne MD Patients

In patients with Duchene muscular dystrophy, muscle cells fail to perform in unison, as if a marching band is falling out of step. A new study in The Journal of Cell Biology reveals how this breakdown leads to the proliferation of stiff fibrotic tissue ... [Published MedIndia - 12 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

NAFLD: A Practical Approach to Treatment

Bedogni G, Miglioli L, Masutti F, et al . Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44–52.Browning JD, Szczepaniak LS, Dobbins R, et al . Prevalence of hepatic steatosis ... [Published General Medicine eJournal - 12 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

CHARLES HORNER, Weymouth: Pembroke dentist makes house calls

I have pulmonary fibrosis and much difficulty getting to Dr. Kyle Findly’s “Smile Boston” office in Pembroke.I received a call from Dr. Findly telling me that he would stop by my home with his tools and his capable and caring ways after he finished at ... [Published Patriot Ledger - 14 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Rachel Lopez

at her home in Flagstaff, AZ after a struggle with pulmonary fibrosis. She was a deeply loved wife, mother, grandmother, sister and friend.Rachel loved and served the Lord with all her heart and was dedicated to His service. She was loved by all she met ... [Published Arizona Daily Sun - 21 hours ago]
Entities: fibrosis, Squirrel, Officer
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

Woodall, MaryAnn "ma"

MaryAnn "MA" WoodallMar 21, 1948 - Oct 14, 2014Resident of SunnyvaleMA passed away peacefully surrounded by her loved ones after a long battle with pulmonary fibrosis.MA worked for the last 11 years at Stanford University in the IT Department.She is survived ... [Published San Jose Mercury News - Oct 19 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 4 reports

CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community

CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community", the CPF incorrectly spelled a newly FDA approved ... [Published MoneyShow.com - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 3 reports

Pulmonary Fibrosis Foundation Applauds The Food And Drug Administration's (FDA) Prompt Decision To Approve Esbriet® (pirfenidone) And OFEV® (nintedanib) For The Treatment Of Idiopathic Pulmonary Fibrosis

CHICAGO, Oct. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) applauds the approval of Esbriet® (pirfenidone) and OFEV® (nintedanib) by the U.S. Food and Drug Administration (FDA) as the first disease-specific therapies ... [Published PR Newswire: Policy & Public Interest - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 4 reports

Esbriet Receives FDA Approval Under 'Breakthrough Status'; Diplomat To Distribute

Diplomat, the nation's largest independent specialty pharmacy, announced today that it has a contract to distribute Esbriet (pirfenidone), which was approved Oct. 15, 2014 by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary ... [Published Benzinga.com - Oct 16 2014]

Quotes

Milo Biotechnology CEO Al Hawkins stated "This significant and long lasting clinical effect provides the basis for planning pivotal clinical studies beginning in 2015; we want to speed delivery of this important therapy to patients with debilitating muscular dystrophies."
"The ability of PBI-4050 to reduce or improve some of the most recognized inflammatory and fibrotic indicators, typically representative of lesions and scars in the lungs, provides a compelling case to aggressively investigate the use of this oral therapy to treat IPF patients" , said Dr John Moran, ProMetic's Chief MedicalMedical officer
...Londei to AnaptysBio's executive leadership team," said HamzaHamza Suria, President and Chief Executive Officer of AnaptysBio. "Dr. Londei's extensive expertise includes successful translational and clinical development of monoclonal antibodies and small molecules for dermatology, rheumatology, neurology, oncology and allergy. Novel anti-inflammatory programs are a strategic priority for AnaptysBio's proprietary pipeline, particularly our first-in-class anti-IL-33 antibody program applicable to a variety of Th2-driven diseases."
...between the injections got frozen or fixed in a developmental time frame and had trouble getting out of it," explains senior author Eric Hoffman. "Because they were getting mixed signals from their neighbors as to where they should be in this regenerative process, they couldn't do the right thing."

More Content

All (740) | News (618) | Reports (0) | Blogs (91) | Audio/Video (0) | Fact Sheets (1) | Press Releases (27)
sort by: Date | Relevance
Vitamin D prevents intestinal fibrosis in IBD [Published Food Consumer - 20 mins ago]
Direct-acting antiviral therapy led to high SVR... [Published Orthopedics Today - 3 hours ago]
Milo Biotechnology's Follistatin Gene Therapy I... [Published BusinessWeek - 3 hours ago]
Printable Body Parts Leap Forward with Printed Jaw [Published PSFK - 4 hours ago]
ProMetic Life Sciences to initiate IPF clinical... [Published Individual.com - 4 hours ago]
AnaptysBio Appoints Dr. Marco Londei to Newly C... [Published TickerTech.com - 6 hours ago]
Roche's Esbriet Gets US FDA Nod for IPF Treatment [Published PharmaAsia - 7 hours ago]
ProMetic Seeks Orphan Status For Lead IPF Drug [Published Bioresearch Online - 11 hours ago]
Muscle Fibrosis Spurred by Out-Of-Step Cells Du... [Published MedIndia - 12 hours ago]
NAFLD: A Practical Approach to Treatment [Published General Medicine eJournal - 12 hours ago]
Genentech Garners FDA Approval of Esbriet for I... [Published Individual.com - 13 hours ago]
CHARLES HORNER, Weymouth: Pembroke dentist make... [Published Patriot Ledger - 14 hours ago]
Hasty: Massey Hill neighborhood garden a place ... [Published Fayetteville Observer - 14 hours ago]
Rachel Lopez [Published Arizona Daily Sun - 21 hours ago]
Woodall, MaryAnn "ma" [Published San Jose Mercury News - Oct 19 2014]
New Film “Second Opinion” Exposes the Truth Abo... [Published Mercola - Oct 18 2014]
SVR after therapy reduced inflammation, fibrosi... [Published Orthopedics Today - Oct 17 2014]
FDA Approves OFEV for the Treatment of Idiopath... [Published PharmTech.com - Oct 17 2014]
BRIEF-Genfit says new patents allowed for GFT50... [Published Reuters UK - Oct 17 2014]
REG-GENFIT : GFT505: NEW PATENTS ALLOWED IN THE... [Published Reuters - Oct 17 2014]
Boehringer Ingelheim's OFEV (nintedanib*) appro... [Published Pharmacy Choice - Oct 17 2014]
Paul Konieczka [Published Burlington County Times - Oct 17 2014]
Armitage coal miner inquest [Published Staffordshire Newsletter - Oct 17 2014]
Boehringer's Ofev one of two drugs approved by ... [Published PMLive - Oct 17 2014]
ProMetic Seeking Orphan Indication for IPF Drug... [Published RT Magazine - Oct 17 2014]
Genentech receives FDA approval for idiopathic ... [Published Individual.com - Oct 17 2014]
Boehringer receives FDA approval for idiopathic... [Published Individual.com - Oct 17 2014]
3D printing helps build upper jaw prosthetic fo... [Published Gizmag - Oct 17 2014]
US FDA approves Boehringer Ingelheim’s Ofev for... [Published PharmaBiz - Oct 17 2014]
Second Wave Anti-HCV Protease Inhibitors [Published General Medicine eJournal - Oct 17 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pulmonary Fibrosis Foundation Applauds The Food... [Published PR Newswire: Policy & Public Interest - Oct 16 2014]
CHICAGO, Oct. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) applauds the approval of Esbriet® (pirfenidone) and OFEV® (nintedanib) by the U.S. Food and Drug Administration (FDA) as the first disease-specific therapies ...
Esbriet, Ofev Approved to Treat Deadly Lung Dis... [Published MedlinePlus Health News - Oct 16 2014]
Drugs help slow decline of idiopathic pulmonary fibrosisSource: HealthDayRelated MedlinePlus Page: Pulmonary Fibrosis ...
FDA Approves Esbriet® (pirfenidone) for the Tre... [Published Business Wire Health News - Oct 15 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet® (pirfenidone) as a treatment for idiopathic pulmonary ...
FDA Approves Esbriet® (pirfenidone) for the Tre... [Published EON Manufacturing - Oct 15 2014]
SOUTH SAN FRANCISCO, Calif.--(EON: Enhanced Online News)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet® (pirfenidone) as a treatment for idiopathic ...
FDA Approves Esbriet® (pirfenidone) for the Tre... [Published Business Wire Manufacturing News - Oct 15 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet® (pirfenidone) as a treatment for idiopathic pulmonary ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
CORRECTION - Two FDA Approvals on Same Day Rene... [Published GlobeNewswire: Advertising News - Oct 16 2014]
Two FDA Approvals on Same Day Renew Hope for Pu... [Published GlobeNewswire: Advertising News - Oct 16 2014]
CPF Applauds Two FDA Approvals Announced Today ... [Published GlobeNewswire: Politics News - Oct 15 2014]
Pulmonary Fibrosis Patients, Families Take Cent... [Published GlobeNewswire: Acquisitions News - Sep 29 2014]
FDA Chooses Four CPF Advocates to Speak on IPF ... [Published GlobeNewswire: Acquisitions News - Sep 25 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.